Anti-MYL9 (pS20) + MYL12A (pS19) + MYL12B (pS20) antibody [EPR27203-65]
- 20ul selling size
- Recombinant
- RabMAb
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal MYL9 phospho S20 antibody. Suitable for WB, Dot and reacts with Transfected cell lysate - Human, Human, Mouse, Synthetic peptide - Human samples.
View Alternative Names
MLC2, MRLC1, MYRL2, MYL9, Myosin regulatory light polypeptide 9, 20 kDa myosin light chain, MLC-2C, Myosin RLC, Myosin regulatory light chain 9, Myosin regulatory light chain MRLC1, LC20, MLCB, MRLC3, RLC, MYL12A, Myosin regulatory light chain 12A, Epididymis secretory protein Li 24, MLC-2B, Myosin RLC, Myosin regulatory light chain MRLC3, HEL-S-24, MRLC2, MYLC2B, MYL12B, Myosin regulatory light chain 12B, MLC-2A, Myosin regulatory light chain 20 kDa, Myosin regulatory light chain MRLC2, SHUJUN-1, MLC-2, MLC20
- WB
Supplier Data
Western blot - Anti-MYL9 (pS20) + MYL12A (pS19) + MYL12B (pS20) antibody [EPR27203-65] (AB316750)
The down-regulation of MYLK is induced by ML-7(PMID : 28737169, PMID : 9036856).
The identity of the higher MW bands are unknown.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.
All lanes:
Western blot - Anti-MYL9 (pS20) + MYL12A (pS19) + MYL12B (pS20) antibody [EPR27203-65] (ab316750) at 1/1000 dilution
Lane 1:
HeLa (human epithelial cell line from cervical adenocarcinoma) treated with 100ng/ml Calyculin A for 15 minutes, whole cell lysate at 45 µg
Lane 2:
HeLa treated with 100ng/ml Calyculin A for 15 minutes then treated with 50uM ML7 for 15 minutes, whole cell lysate at 45 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 20 kDa,36 kDa
false
Exposure time: 48s
- WB
Supplier Data
Western blot - Anti-MYL9 (pS20) + MYL12A (pS19) + MYL12B (pS20) antibody [EPR27203-65] (AB316750)
The identity of the higher MW bands are unknown.
In Western blot, Anti-Histone H3 antibody [EPR16987] - Nuclear Marker and ChIP Grade (ab176842) staining at 1/100000 dilution.
In Western blot, Anti-MYL9 antibody [EPR13012 (2)] (ab191393) staining at 1/1000 dilution.
All lanes:
Western blot - Anti-MYL9 (pS20) + MYL12A (pS19) + MYL12B (pS20) antibody [EPR27203-65] (ab316750) at 1/1000 dilution
Lane 1:
Untreated HeLa (human epithelial cell line from cervical adenocarcinoma) whole cell lysate (untreated membrane) at 45 µg
Lane 2:
HeLa treated with 100ng/ml Calyculin A for 15 minutes, whole cell lysate (untreated membrane) at 45 µg
Lane 3:
Untreated HeLa (human epithelial cell line from cervical adenocarcinoma) whole cell lysate (alkaline phosphatase treated membrane) at 45 µg
Lane 4:
HeLa treated with 100ng/ml Calyculin A for 15 minutes, whole cell lysate (alkaline phosphatase treated membrane) at 45 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 20 kDa,15 kDa
false
Exposure time: 70s
- WB
Supplier Data
Western blot - Anti-MYL9 (pS20) + MYL12A (pS19) + MYL12B (pS20) antibody [EPR27203-65] (AB316750)
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) staining at 1/10000 dilution.
All lanes:
Western blot - Anti-MYL9 (pS20) + MYL12A (pS19) + MYL12B (pS20) antibody [EPR27203-65] (ab316750) at 1/1000 dilution
Lane 1:
Untreated NIH/3T3 (mouse embryonic fibroblast) whole cell lysate (untreated membrane) at 50 µg
Lane 2:
NIH/3T3 treated with 100nM Calycin A for 30min whole cell lysateug (untreated membrane) at 50 µg
Lane 3:
Untreated NIH/3T3 (mouse embryonic fibroblast) whole cell lysate (alkaline phosphatase treated membrane) at 50 µg
Lane 4:
NIH/3T3 treated with 100nM Calycin A for 30min whole cell lysateug (alkaline phosphatase treated membrane) at 50 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 20 kDa,124 kDa
false
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-MYL9 (pS20) + MYL12A (pS19) + MYL12B (pS20) antibody [EPR27203-65] (AB316750)
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.
In Western blot, Anti-6X His tag® antibody [EPR20547] - ChIP Grade (ab213204) staining at 1/5000 dilution.
In Western blot, Anti-MYL9 antibody [EPR13012 (2)] (ab191393) staining at 1/1000 dilution.
All lanes:
Western blot - Anti-MYL9 (pS20) + MYL12A (pS19) + MYL12B (pS20) antibody [EPR27203-65] (ab316750) at 1/1000 dilution
Lane 1:
293T (human embryonic kidney epithelial cell) cells transfected with human MYL9 expression vector containing a myc-His-tag® then treated with 100/ml calyculin for 15 minutes, whole cell lysate at 20 µg
Lane 2:
293T (human embryonic kidney epithelial cell) cells transfected with human MYL9 (S20A mutant) expression vector containing a myc-His-tag® then treated with 100/ml calyculin for 15 minutes, whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 25 kDa,36 kDa
false
Exposure time: 180s
- Dot
Supplier Data
Dot Blot - Anti-MYL9 (pS20) + MYL12A (pS19) + MYL12B (pS20) antibody [EPR27203-65] (AB316750)
Dot blot analysis of MYL9 (pS20) + MYL12A (pS19) + MYL12B (pS20) using ab316750 at 1 : 1000 (0.515 ug/ml) followed by a Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1 : 100,000 dilution.
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Lane 1 : MYL9 (phospho S20) peptide
Lane 2 : MYL9 non-phospho peptide
Lane 3 : MYL9 (phospho S20 + T19) peptide
Lane 4 : MYL9 (phospho T19) peptide
This antibody does not cross-react with human MYL9 (phospho T19) and MYL9 (phospho S20 + T19).
All lanes:
Dot Blot - Anti-MYL9 (pS20) + MYL12A (pS19) + MYL12B (pS20) antibody [EPR27203-65] (ab316750) at 1/1000 dilution
Lane 1:
MYL9 (phospho S20) peptide
Lane 2:
MYL9 non-phospho peptide
Lane 3:
MYL9 (phospho S20 + T19) peptide
Lane 4:
MYL9 (phospho T19) peptide
Secondary
All lanes:
Dot Blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
false
Exposure time: 180s
Related conjugates and formulations (1)
-
Anti-MYL9 (pS20) + MYL12A (pS19) + MYL12B (pS20) antibody [EPR27203-65] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com